Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Endovascular treatment for thoracoabdominal and paravisceral aortic aneurysms

Official title: Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

Run by University of California, San Francisco · NCT00483249 · Data updated 2026-11-12

This study is testing a less invasive way to treat certain types of aortic aneurysms using a stent-graft to see if it can reduce pain and recovery time compared to traditional surgery.

More Thoracoabdominal Aortic Aneurysm trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment250 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations2 sites (San Francisco, California and 1 other locations)
StatusRecruiting
StartedMay 2005
Main results expectedDecember 2028
Study endsDecember 2028
Registry record updatedNovember 10, 2026
Trial IDNCT00483249 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals with significant aortic aneurysms who meet specific size and anatomical criteria and have a life expectancy of more than two years.

Probably not a fit

Patients with free ruptures of the aneurysm, pregnancy, or serious systemic infections are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and effectiveness of an endovascular approach to treat thoracoabdominal and paravisceral abdominal aortic aneurysms. The procedure involves placing a stent-graft over the aneurysm through small incisions in the groins and arm, as opposed to traditional surgery which requires a large incision. The goal is to reduce pain, minimize complications, and shorten hospital stays compared to standard surgical methods. Participants will be monitored for outcomes related to the success of the stent-graft placement and overall recovery.

Why it matters

Potential benefit: If successful, this approach could offer a less invasive treatment option with fewer complications for patients with aortic aneurysms.

How similar studies have gone: Other studies have shown promising results with endovascular techniques for aortic aneurysms, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria

1. Aortic aneurysms:

   * greater than or equal to 6 cm in diameter in men,
   * greater than or equal to 5.5 cm in diameter in women,
   * and/or larger than 5 cm in diameter and enlarging at a rate of more than 5 mm/year,
   * and/or iliac aneurysms larger than 4 cm in diameter.
2. Anticipated mortality comparable to published rates with conventional surgical treatment.
3. Life expectancy more than 2 years.
4. Ability to give informed consent.
5. Willingness to comply with follow-up schedule.
6. Suitable arterial anatomy for endovascular repair.

Exclusion Criteria

1. Free rupture of the aneurysm.
2. Pregnancy.
3. Known allergy to Nitinol, stainless steel, or polyester.
4. Unwillingness or inability to comply with the follow up schedule.
5. Serious systemic or groin infection.
6. Uncorrectable coagulopathy.

Where it's running

  • Division of Vascular Surgery, SFVAMC
    San Francisco, California, United States
    Recruiting
  • Division of Vascular Surgery, UCSF
    San Francisco, California, United States
    Recruiting

Study contacts

  • Principal investigator: Warren J Gasper, MD — University of California, San Francisco
  • Study coordinator: Warren J Gasper, MD
  • Email: warren.gasper@ucsf.edu
  • Phone: 415 750 2115

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.